Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease.

about

Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease.

Item

http://www.wikidata.org/entity/Q38591052

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Siltuximab: A Review in Idiopa ...... ulticentric Castleman Disease.

@en

type

Item

label

Siltuximab: A Review in Idiopa ...... ulticentric Castleman Disease.

@en

prefLabel

Siltuximab: A Review in Idiopa ...... ulticentric Castleman Disease.

@en

P1476

Siltuximab: A Review in Idiopa ...... ulticentric Castleman Disease.

@en

P2860

Tocilizumab

A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease.

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma.

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.

Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levels

Patient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab.

Castleman's disease: from basic mechanisms to molecular therapeutics

Multicentric Castleman's disease: a challenging diagnosis.

Siltuximab: first global approval.

P2888

s40259-015-0142-5

P304

399-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40259-015-0142-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Katherine A Lyseng-Williamson

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26394632

http://www.w3.org/2001/XMLSchema#string

Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease.

about

Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698